Medidata Solutions Inc (NASDAQ:MDSO) gets upgraded to Neutral by JPMorgan Chase & Co.

Analyst Ratings For Medidata Solutions Inc (NASDAQ:MDSO)

Story continues below

Today, Medidata Solutions Inc (NASDAQ:MDSO) stock received an upgrade by JPMorgan Chase & Co. from Underweight to Neutral.

There are 10 Hold Ratings, 3 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on Medidata Solutions Inc (NASDAQ:MDSO) is Hold with a consensus target price of $84.3483 per share, a potential 7.72% downside.

Some recent analyst ratings include

  • 6/12/2019-Medidata Solutions Inc (NASDAQ:MDSO) gets upgraded to Neutral by JPMorgan Chase & Co.
  • 6/12/2019-Medidata Solutions Inc (NASDAQ:MDSO) gets downgraded to Market Perform by William Blair
  • 6/12/2019-Medidata Solutions Inc (NASDAQ:MDSO) gets downgraded to Neutral by Guggenheim with a price target of $92.25
  • 5/1/2019-Medidata Solutions Inc (NASDAQ:MDSO) gets downgraded to Neutral by Dougherty & Co
  • 4/24/2019-Medidata Solutions Inc (NASDAQ:MDSO) gets downgraded to Hold by SunTrust Banks with a price target of $79.00
  • 4/23/2019-Medidata Solutions Inc (NASDAQ:MDSO) gets downgraded to Market Perform by Wells Fargo & Co with a price target of $90.00
  • On 6/6/2019 Robert Taylor, Director, sold 3,294 with an average share price of $90.88 per share and the total transaction amounting to $299,358.72.
  • On 3/12/2019 Daniel Patrick Shannon, EVP, sold 19,725 with an average share price of $75.17 per share and the total transaction amounting to $1,482,728.25.
  • On 3/1/2019 Michael Pray, EVP, sold 15,000 with an average share price of $76.50 per share and the total transaction amounting to $1,147,500.00.
  • On 2/6/2019 Rouven Bergmann, CFO, sold 12,512 with an average share price of $75.00 per share and the total transaction amounting to $938,400.00.
  • On 1/7/2019 Robert Taylor, Director, sold 2,120 with an average share price of $64.70 per share and the total transaction amounting to $137,164.00.
  • On 12/3/2018 Rouven Bergmann, CFO, sold 10,000 with an average share price of $79.00 per share and the total transaction amounting to $790,000.00.
  • On 11/28/2018 Rouven Bergmann, CFO, sold 10,000 with an average share price of $75.00 per share and the total transaction amounting to $750,000.00.

About Medidata Solutions Inc (NASDAQ:MDSO)
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner support, and e-learning and training. Read More…

Recent Trading Activity for Medidata Solutions Inc (NASDAQ:MDSO)
Shares of Medidata Solutions Inc closed the previous trading session at 91.48 −3.27 3.45% with shares trading hands.

An ad to help with our costs